Propylthiouracil-induced lupus-like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus

Internal Medicine

Volumn 41, Issue 12, 2002, Pages 1204-1208

  Yamada, Akemi ^a   Sato, Kanji ^a   Hara, Mitsuhiko ^b   Tochimoto, Akiko ^a   Takagi, Sachiko ^a   Hizuka, Naomi ^a   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

Author keywords

Anti neutrophil cytoplasmic antibody (ANCA); Graves' disease; Lupus like syndrome; Propylthiouracil (PTU); Systemic lupus erythematosus (SLE)

Indexed keywords

ANALGESIC AGENT; ANTITHYROID AGENT; C REACTIVE PROTEIN; DNA ANTIBODY; DOUBLE STRANDED DNA; HLA DR ANTIGEN; IMMUNOGLOBULIN G; LIOTHYRONINE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; POTASSIUM IODIDE; PREDNISOLONE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADOLESCENT; ALLELE; ARTHRALGIA; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FEVER; GRAVES DISEASE; HEMATURIA; HUMAN; HYPERGAMMAGLOBULINEMIA; LUPUS ERYTHEMATOSUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALAISE; NEUTROPENIA; PARENT; SIBLING; SWEATING; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA; TREMOR;

EID: 0036967548     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.1204     Document Type: Article

References (40)

1. Best MM, Duncan CH. A lupus-like syndrome following propylthiouracil administration. J Kky Med Assoc 62: 47-49, 1964.
2. Amrhein JA, Kenny FM, Ross D. Granulocytopenia, lupus-like syndrome and other complications of propylthiouracil therapy. J Pediatr 76: 54-63, 1970.
3. Librik L, Sussman L, Bejar R, Clayton GW. Thyrotoxicosis and collagen-like disease in three sisters of American Indian extraction. J Pediatr 76: 64-68, 1970.
4. Hung W, August GP. A collagen-like syndrome associated with antithyroid therapy. J Pediatr 82: 852-854, 1973.
5. Searles RP, Plymate SR, Troup GM. Familial thionamide-induced lupus syndrome in thyrotoxicosis. J Rheumatol 8: 498-500, 1981.
6. Takuwa N, Kojima I, Ogata E. Lupus-like syndrome - a rare complication in thionamide treatment for Graves' disease. Endocrinol Jpn 28: 663-667, 1981.
7. Berkman EM, Orlin JB, Wolfsdorf J. An antineutrophil antibody associated with a propylthiouracil induced lupus-like syndrome. Transfusion 23: 135-138, 1983.
8. Sato K, Miyakawa M, Han DC, et al. Graves' disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil. J Endocrinol Invest 8: 551-555, 1985.
9. Yoshikawa H, Kawai K, Murayama K, et al. A case with Graves' disease who developed SLE-like symptoms and insulin-autoimmune syndrome. Horumon to Rinshou 37: 200-203, 1988 (in Japanese).
10. Gomibuchi Y, Takano Y, Itabashi H, Naito T, Sato A, Takeuchi Y. A case of methimazole-induced lupus-like syndrome in a Graves' hyperthyroid patient. Sougou Rinshou 3: 771-775, 1989 (in Japanese).
11. Ito S, Takada Y, Ojima T, et al. Drug-induced lupus-like syndrome: A rare complication in methimazole treatment of Graves'disease. Saishin Igaku 46: 194-199, 1991 (in Japanese).
12. Reveille JD. Major histocompatibility complex class II and non-major histocompatibility complex genes in the pathogenesis of systemic lupus erythematosus. in: Systemic Lupus Erythematosus, Ed. Lahita RG, third edition, Academic Press, New York, 1999: 67-89.
13. Mongrey A-B, Hess E. Drug and environmental lupus: clinical manifestations and differences. in: Systemic Lupus Erythematosus, edited by Lahita RG, third edition, Academic Press, New York, 199: 929-943.
14. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T. Immunoglobulins of untreated Graves' patients with or without TSH receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Thyroid 9: 979-988, 1999.
15. Eng PHK, Braverman LE. Iodine and Graves' disease. in Graves' disease: Pathogenesis and Treatment, Rapaport B, McLachlan SM, Eds, Kluwer Academic Press, Boston, 2000: 235-247.
16. Sato-Matsumura K, Koizumi H, Matsumura T, Takahashi T, Adachi K, Ohkawara A. Lupus erythematosus-like syndrome induced by thiamazole and propylthiouracil. J Dermatol 21: 501-507, 1994.
17. Kawachi Y, Nukaga H, Hoshino M, Iwata M, Otsuka F. ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin Exp Dermatol 20: 345-347, 1995.
18. Imokawa S, Kitazawa H, Sato A, et al. A patient with drug-related lupus induced by propylthiouracil. Jpn J Allergol 46: 325(abstract 261), 1997 (in Japanese).
19. Imamura T, Osone S, Ijuin I, et al. A case of drug-induced lupus associated with PTU which reveals positive ANCA. Clin Pediatr Endocrinol 7: 171 (abstract 159), 1998.
20. Tanimoto T, Ojima T, Nishisaka H, Kikuchi I, Ueda A. A case with ANCA-positive systemic lupus erythematosus induced by propylthiouracil. The Ryumachi 39: 472 (abstract C1-11), 1999 (in Japanese).
21. Ishigame M, Urabe H, Suda T. A case with drug-induced lupus who developed ANCA-related vasculitis and anti-cardiolipin antibody after administration of propylthiouracil. Folia Endocrinol Jpn 75: 183 (abstract P-324), 1999 (in Japanese).
22. Noh JY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf) 54: 651-654, 2001.
23. Hirose S, Ogawa S, Nishimura H, Hashimoto H, Shirai T. Association of HLA-DR2/DR4 heterozygosity with systemic lupus erythematosus in Japanese patients. J Rheumatol 15: 1489-1492, 1988.
24. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and anti-neutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342: 651-652, 1993.
25. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124: 986-988. 1994.
26. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves'disease: report of three adult cases. Am J Kidney Dis 26: 774-780, 1995.
27. Prasad GV, Bastacky S, Johnson JP. Propylthiouracil-induced diffuse proliferative lupus nephritis: review of immunological complications. J Am Soc Nephrol 8: 1205-1210, 1997.
28. Gunton JE, Stiel J, Caterson RJ, McElduff A. Clinical case seminar: Antithyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 84: 13-16, 1999.
29. Harper L, Cockwell P, Savage COS. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant 13: 455-458, 1998.
30. Fujieda M, Hattori M, Kurayama H, Koitabashi Y, Members and Coworkers of the Japanese Society for Pediatric Nephrology. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol 13: 437-445, 2002.
31. Yung RL, Richardson BC. Pathophysiology of drug-induced lupus. in: Systemic Lupus Erythematosus, Lahita RG, Ed., third edition, Academic Press, New York, 1999: 909-928.
32. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 266: 810-813, 1994.
33. Lee E, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. Biochem Pharmacol 37: 2151-2153, 1988.
34. Sato K, Mimura H, Kato S, et al. Serum propylthiouracil concentration in patients with Graves' disease with various clinical courses. Acta Endocrinol 104: 189-194, 1983.
35. von Schmiedeberg S, Hanten U, Goebel C, Schuppe HC, Uetrecht J, Gleichmann E. T cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo. Clin Immunol Immunopathol 80: 162-170, 1996.
36. Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab 85: 4270-4273, 2000.
37. Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 10: 595-599, 2000.
38. Wartofsky L, Glinoer D, Solomon B, et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1: 129-135, 1991.
39. Rivkees SA. Management of Graves' disease in children. in: Graves' Disease: Pathogenesis and Treatment, Rapaport B, McLachlan SM, Eds, 2000: 185-203.
40. Kraiem Z, Newfield RS. Graves' disease in childhood. J Pediatr Endocrinol Metab 14: 229-243, 2001.